138 related articles for article (PubMed ID: 11594579)
1. Analysis of clonality in cutaneous T cell lymphoma and associated diseases.
Wood GS
Ann N Y Acad Sci; 2001 Sep; 941():26-30. PubMed ID: 11594579
[TBL] [Abstract][Full Text] [Related]
2. Cutaneous lymphoproliferative disorders: Back to the future.
Willemze R
J Cutan Pathol; 2024 Jun; 51(6):468-476. PubMed ID: 38499969
[TBL] [Abstract][Full Text] [Related]
3. Application of Blood Lymphocyte Immunophenotype and TCR Gene Rearrangement in the Diagnosis of CTCL.
You R; Wang Y; Gong Y; Sun J; Lu Y; Miao L; Guo S; Qu C
Clin Lab; 2024 Feb; 70(2):. PubMed ID: 38345989
[TBL] [Abstract][Full Text] [Related]
4. Immunosequencing applications in cutaneous T-cell lymphoma.
Mandel J; Gleason L; Joffe D; Bhatti S; Nikbakht N
Front Immunol; 2023; 14():1300061. PubMed ID: 38213330
[TBL] [Abstract][Full Text] [Related]
5. Molecular techniques drive cutting edge advancements in management of cutaneous T cell lymphoma.
Lefebvre MN; Borcherding N; Reis RJ; Mou E; Liu V; Jabbari A
Front Immunol; 2023; 14():1228563. PubMed ID: 37654486
[TBL] [Abstract][Full Text] [Related]
6. Single-Cell Profiling of Cutaneous T-Cell Lymphoma Reveals Underlying Heterogeneity Associated with Disease Progression.
Borcherding N; Voigt AP; Liu V; Link BK; Zhang W; Jabbari A
Clin Cancer Res; 2019 May; 25(10):2996-3005. PubMed ID: 30718356
[TBL] [Abstract][Full Text] [Related]
7. TRBC1 immunohistochemistry distinguishes cutaneous T-cell lymphoma from inflammatory dermatitis: A retrospective analysis of 39 cases.
Nocco SE; Ewalt MD; Moy AP; Lewis NE; Zhu M; Lezcano C; Busam K; Pulitzer M
J Am Acad Dermatol; 2024 Apr; 90(4):839-841. PubMed ID: 38061444
[No Abstract] [Full Text] [Related]
8. Multimodal single-cell analysis of cutaneous T-cell lymphoma reveals distinct subclonal tissue-dependent signatures.
Herrera A; Cheng A; Mimitou EP; Seffens A; George D; Bar-Natan M; Heguy A; Ruggles KV; Scher JU; Hymes K; Latkowski JA; Ødum N; Kadin ME; Ouyang Z; Geskin LJ; Smibert P; Buus TB; Koralov SB
Blood; 2021 Oct; 138(16):1456-1464. PubMed ID: 34232982
[TBL] [Abstract][Full Text] [Related]
9. New Genetic Markers of Skin T-Cell Lymphoma Treatment.
Vašků V; Fialová P; Vašků A
Genes (Basel); 2024 Mar; 15(3):. PubMed ID: 38540417
[TBL] [Abstract][Full Text] [Related]
10. Structural alterations of the FAS gene in cutaneous T-cell lymphoma (CTCL).
Wu J; Siddiqui J; Nihal M; Vonderheid EC; Wood GS
Arch Biochem Biophys; 2011 Apr; 508(2):185-91. PubMed ID: 21036138
[TBL] [Abstract][Full Text] [Related]
11. Single-cell RNA sequencing unveils the communications between malignant T and myeloid cells contributing to tumor growth and immunosuppression in cutaneous T-cell lymphoma.
Du Y; Cai Y; Lv Y; Zhang L; Yang H; Liu Q; Hong M; Teng Y; Tang W; Ma R; Wu J; Wu J; Wang Q; Chen H; Li K; Feng J
Cancer Lett; 2022 Dec; 551():215972. PubMed ID: 36265653
[TBL] [Abstract][Full Text] [Related]
12. Epigenetics of cutaneous T-cell lymphoma: biomarkers and therapeutic potentials.
Lai P; Wang Y
Cancer Biol Med; 2021 Feb; 18(1):34-51. PubMed ID: 33628583
[TBL] [Abstract][Full Text] [Related]
13. Role of Antigenic Stimulation in Cutaneous T-Cell Lymphomas.
Gumina ME; Hooper MJ; Zhou XA; Koralov SB
J Invest Dermatol; 2024 Apr; 144(4):755-763. PubMed ID: 38149950
[TBL] [Abstract][Full Text] [Related]
14. What Is New in Cutaneous T Cell Lymphoma?
Morgenroth S; Roggo A; Pawlik L; Dummer R; Ramelyte E
Curr Oncol Rep; 2023 Nov; 25(11):1397-1408. PubMed ID: 37874473
[TBL] [Abstract][Full Text] [Related]
15. Blocking STAT3/5 through direct or upstream kinase targeting in leukemic cutaneous T-cell lymphoma.
Sorger H; Dey S; Vieyra-Garcia PA; Pölöske D; Teufelberger AR; de Araujo ED; Sedighi A; Graf R; Spiegl B; Lazzeri I; Braun T; Garces de Los Fayos Alonso I; Schlederer M; Timelthaler G; Kodajova P; Pirker C; Surbek M; Machtinger M; Graier T; Perchthaler I; Pan Y; Fink-Puches R; Cerroni L; Ober J; Otte M; Albrecht JD; Tin G; Abdeldayem A; Manaswiyoungkul P; Olaoye OO; Metzelder ML; Orlova A; Berger W; Wobser M; Nicolay JP; André F; Nguyen VA; Neubauer HA; Fleck R; Merkel O; Herling M; Heitzer E; Gunning PT; Kenner L; Moriggl R; Wolf P
EMBO Mol Med; 2022 Dec; 14(12):e15200. PubMed ID: 36341492
[TBL] [Abstract][Full Text] [Related]
16. Cathepsin W, T-cell receptor-associated transmembrane adapter 1, lymphotactin and killer cell lectin like receptor K1 are sensitive and specific RNA biomarkers of canine epitheliotropic lymphoma.
Olayinka JT; Nagarkar A; Ma DJ; Wong NB; Romasco A; Piedra-Mora C; Wrijil L; David CN; Gardner HL; Robinson NA; Hughes KL; Barton B; London CA; Almela RM; Richmond JM
Front Vet Sci; 2023; 10():1225764. PubMed ID: 38026637
[TBL] [Abstract][Full Text] [Related]
17. Health-related quality of life and economic implications of cutaneous T-cell lymphoma.
Semenov YR; Rosenberg AR; Herbosa C; Mehta-Shah N; Musiek AC
Br J Dermatol; 2020 Jan; 182(1):190-196. PubMed ID: 30920642
[TBL] [Abstract][Full Text] [Related]
18. GATA-3-dependent Gene Transcription is Impaired upon HDAC Inhibition.
Geng X; Wang C; Abdelrahman S; Perera T; Saed B; Hu YS; Wolfe A; Reneau J; Murga-Zamalloa C; Wilcox RA
Clin Cancer Res; 2024 Mar; 30(5):1054-1066. PubMed ID: 38165708
[TBL] [Abstract][Full Text] [Related]
19. Cutaneous T-cell lymphoma (CTCL) patients' understanding of illness and perception of follow-up.
Torosian A; Albucker SJ; Gowda G; Boh E; Bitar C
Int J Dermatol; 2023 Dec; 62(12):e645-e647. PubMed ID: 37548249
[No Abstract] [Full Text] [Related]
20. Clusters, crop dusters, and myth busters: a scoping review of environmental exposures and cutaneous T-cell lymphoma.
Gordon ER; Adeuyan O; Schreidah CM; Chen C; Trager MH; Lapolla BA; Fahmy LM; Weng C; Geskin LJ
Ital J Dermatol Venerol; 2023 Dec; 158(6):467-482. PubMed ID: 38015484
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]